Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTR3B pseudogene 2 (ACTR3BP2, FKSG73) is a human pseudogene that shares sequence similarity with the actin-related protein 3B gene (ACTR3B), but does not encode a functional protein[6][8][5]. Pseudogenes are generally considered non-coding segments that may serve as genomic markers but lack direct biological activity. Although some studies speculate ACTR3BP2 may play roles in cell growth or development, there is no experimentally validated molecular function or disease relevance[4][6]. No evidence suggests it acts as a receptor, enzyme, transporter, or other conventional drug target.\n\nBased on current search results, ACTR3BP2 does not fit classification as a therapeutic target. It is best described as a human pseudogene, with FKSG73 as its main alias.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTR3B pseudogene 2 (ACTR3BP2).